Skip to main content
👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources. Claim this profile →
Dr Mark Hill
Trust score 8/100 Accepting new patients

Dr

Dr Mark Hill

Oncology

English
13,100+ Patients seen
16 Years in practice
4 Publications
1 Languages spoken

About

Dr Mark Hill is a senior Consultant Medical Oncologist at the Kent Oncology Centre in Maidstone and in addition to this is Clinical Director of the KSS Research Network. He specialises in the treatment of gastrointestinal cancers including colorectal cancer, upper gastrointestinal cancer (stomach, oesophagus and pancreas) and neuroendocrine tumours.

Dr Hill trained at St George's Hospital, London and completed his Medical Oncology speciality training at Guy's Hospital. He went on to do a Research Fellowship at the Institute of Cancer Research and obtained an MD from the University of London. In 1998 he was appointed as a Consultant to the GI Unit at the Royal Marsden Hospital. In 2003 he took up post a full time as Lead Medical Oncologist in the Kent Cancer Network and was made a Fellow of the Royal College of Physicians. He was made an Honorary Senior Lecturer at the University of Kent in 2004.

Dr Hill has an active interest in clinical investigations and is Clinical Lead of the Kent, Surrey & Sussex Cancer Research Network and sits on the NCRI advanced colon cancer trials sub-committee. He has been published in over 60 peer reviewed papers in high ranking journals and regularly is invited to speak at National and International conferences. He is a founding Trustee the Kent Cancer Trust, a local cancer research charity.

Outside of work he enjoys playing cricket, cycling, travelling and spending time with his wife and four children.

Diseases, Medical Tests and Treatments
• Chemotherapy

• Cancers of Unknown Primary Site

• Colorectal Cancer

• Gastro-intestinal cancers

• Liver Cancer

• Neuro-endrocine Tumours (NETs)

• Oesophageal Cancer

• Pancreatic Cancer

• Stomach Cancer

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Dr Mark Hill

Education & training

  1. 2000–2006 MD · Medicine and Surgery
    Universidad de Navarra
  2. 2006–2010 Residency · Oncology
    Universitat de València

Career & appointments

  1. 2010-09–2011-08 Junior consultant
    Universidad de Navarra Teaching Hospital — Oncology

Licenses & insurance

Medical licenses

— Organización Médica Colegial de España (OMC)
#-486187 active · expires 2028-12-31

Board certifications

European Board of Oncology
#EB-78136711 · issued 2011 · renewal 2021
Malpractice insurance: AXA Healthcare Liability · 4,000,000 EUR coverage · No claims on file

Procedures performed

ProcedureCodeLifetime count
GP consultation 99213 2,299
Annual physical exam 99395 2,645
Vaccination administration 90471 605
Minor procedure (skin) 17110 282

Services & pricing

ServiceDurationModalityPrice
New patient consultation (60m) 60 min in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 min in_clinic|telemed|phone 90.00 EUR
Vaccination administration 30 min in_clinic 450.00 EUR
Minor procedure (skin) 120 min in_clinic 180.00 EUR

Office, team & in practice

Mark Hill
HEADSHOT
Mark Hill in consultation
IN OFFICE
Mark Hill with the team
WITH TEAM
Mark Hill at a conference
CONFERENCE

Videos

introduction · 117s
Meet Mark Hill

Research & publications

h-index: 7 · i10: 9

  1. Validation of clinical scoring in Oncology
    Mark Hill, et al. · European Journal of Medicine, 2026
    DOI: 10.5819/euroclin.2026.0 · PMID: 37677503 · cited by 171
  2. Long-term follow-up of Oncology across
    Mark Hill, et al. · European Journal of Medicine, 2025
    DOI: 10.4587/euroclin.2025.1 · PMID: 36629434 · cited by 41
  3. Validation of clinical scoring in Oncology
    Mark Hill, et al. · European Journal of Medicine, 2024
    DOI: 10.4296/euroclin.2024.2 · PMID: 35121281 · cited by 103
  4. Long-term follow-up of Oncology across
    Mark Hill, et al. · European Journal of Medicine, 2023
    DOI: 10.4225/euroclin.2023.3 · PMID: 36734299 · cited by 141

Invited talks

  • Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
  • Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract

Awards & memberships

Awards

  • 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional

Society memberships

  • WONCA Europe — Family Doctors — Member · since 2011
  • national college of family doctors — Member · since 2011
  • European Union of Medical Specialists (UEMS) — Member · since 2011

Patient reviews

★ 0.00 248 verified reviews
Bedside Manner
0.05
Knowledge
0.08
Wait Time
3.80
Staff Friendliness
0.02
Ease Of Appointment
4.00
Value For Money
4.10
Would Recommend Pct
4
  • ★ 5 verified visit

    “Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”

    — Anna B. · 2026-05-25

  • ★ 5 verified visit

    “Took time to listen and reviewed all my previous results. I would absolutely recommend.”

    — Marco V. · 2026-04-20

  • ★ 4 verified visit

    “Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”

    — Helena F. · 2026-04-03

Articles by this doctor

  • Patient education Patient guide to Oncology
  • Awareness When should you see a oncology?

For international patients

Coordinator
Patient liaison · dr.mark.hill@euroclinics.example

Similar specialists

Browse all →